REFERENCES
1. Ahmadi A, Kini A, Narula J. Discordance between ischemia and stenosis, or PINSS and NIPSS: are we ready for new vocabulary? JACC Cardiovasc Imaging 2015;8:111-4.
2. Johnson NP, Kirkeeide RL, Gould KL. Coronary anatomy to predict physiology: fundamental limits. Circ Cardiovasc Imaging 2013;6:817-32.
3. Kern MJ, Samady H. Current concepts of integrated coronary physiology in the catheterization laboratory. J Am Coll Cardiol 2010;55:173-85.
4. Pijls NH, van Son JA, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 1993;87:1354-67.
5. Pijls NH, De Bruyne B, Peels K, Van Der Voort PH, Bonnier HJ, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996;334:1703-08.
6. Pijls NH, van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow- up of the DEFER Study. J Am Coll Cardiol 2007;49:2105-11.
7. Tonino PA, De Bruyne B, Pijls NH, Siebert V, Ikeno F, et al. Fractional flow reserve vs. angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360:213-24.
8. Pijls NH, Fearon WF, Tonino PAO, Siebert U, Ikeno F, et al. Fractional flow reserve vs. angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease. J Am Coll Cardiol 2010;56:177-184.
9. De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, et al; FAME 2 Trial Investigators. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 2012;367:991-1001.
10. De Bruyne B, Fearon WF, Pijls NH, Barbato E, Tonino P, et al; FAME 2 Trial Investigators. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med 2014;371:1208-17.
11. Johnson NP, Tóth GG, Lai D, Zhu H, Açar G, et al. Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes. J Am Coll Cardiol 2014;64:1641-54.
12. Mangiacapra F, Barbato E. From SYNTAX to FAME, a paradigm shift in revascularization strategies: the key role of fractional flow reserve in guiding myocardial revascularization. J Cardiovasc Med 2011;12:538-542.
13. Nam CW, Mangiacapra F, Entjes R, Chung IS, Sels JW, et al; FAME Study Investigators. Functional SYNTAX score for risk assessment in multivessel coronary artery disease. J Am Coll Cardiol 2011;58:1211-8.
14. Harskamp RE, Alexander JH, Ferguson TB, Hager R, Mack MJ, et al. Frequency and predictors of internal mammary artery graft failure and subsequent clinical outcomes: insights from the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV trial. Circulation 2016;133:131-8.
15. Toth GG, Johnson NP, Jeremias A, Pellicano M, Vranckx P, et al. Standardization of Fractional Flow Reserve Measurements. J Am Coll Cardiol 2016;68:742-53.
16. Kern MJ. My approach to the patient diagnosed with significant left main disease: Use of FFR, IVUS, and OCT. Trends Cardiovasc Med 2016;26:660-1.
17. Johnson NP, Gould KL, Di Carli MF, Taqueti VR. Invasive FFR and Noninvasive CFR in the Evaluation of Ischemia: What Is the Future? J Am Coll Cardiol 2016;67:2772-88.
18. Engstrom T, Kelbaek H, Helqvist S, Høfsten DE, Kløvgaard L, et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3- PRIMULTI): an open-label, randomised controlled trial. Lancet 2015;386:665-71.
19. Toth GG, De Bruyne B, Rusinaru D, Di Gioia G, Bartunek J, et al. Impact of Right Atrial Pressure on Fractional Flow Reserve Measurements: Comparison of Fractional Flow Reserve and Myocardial Fractional Flow Reserve in 1,600 Coronary Stenoses. JACC Cardiovasc Interv 2016;9:453-9.
20. van de Hoef TP, Nolte F, EchavarrIa-Pinto M, van Lavieren MA, Damman P, et al. Impact of hyperaemic microvascular resistance on fractional flow reserve measurements in patients with stable coronary artery disease: insights from combined stenosis and microvascular resistance assessment. Heart 2014;100:951-9.
21. Meuwissen M, Chamuleau SA, Siebes M, Schotborgh CE, Koch KT, et al. Role of variability in microvascular resistance on fractional flow reserve and coronary blood flow velocity reserve in intermediate coronary lesions. Circulation 2001;103:184-7.
22. Di Gioia G, Pellicano M, Toth GG, Casselman F, Adjedj J, et al. Fractional Flow Reserve-Guided Revascularization in Patients With Aortic Stenosis. Am J Cardiol 2016;117:1511-5.
23. Pellicano M, De Bruyne B, Toth GG, Casselman F, Wijns W, et al. Fractional flow reserve to guide and to assess coronary artery bypass grafting. Eur Heart J 2016;38:1959-68.
24. Aggarwal V, Stanislawski MA, Maddox TM, Nallamothu BK, Grunwald G, et al. Safety and effectiveness of drug-eluting versus bare-metal stents in saphenous vein bypass graft percutaneous coronary interventions: insights from the Veterans Affairs CART program. J Am Coll Cardiol 2014;64:1825-36.
25. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, et al; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2019;40:87-165.
26. Dimitrova KR, Hoffman DM, Geller CM, Dincheva G, Ko W, et al. Arterial grafts protect the native coronary vessels from atherosclerotic disease progression. Ann Thorac Surg 2012;94:475-81.
27. Weintraub WS, Grau-Sepulveda MV, Weiss JM, O’Brien SM, Peterson ED, et al. Comparative effectiveness of revascularization strategies. N Engl J Med 2012;366:1467-76.
28. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961-72.
29. Mohr FW, Morice MC, Kappetein AP, Feldman TE, Ståhle E, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013;381:629-38.
30. Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, et al; FREEDOM Trial Investigators. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 2012;367:2375-84.
31. Park SJ, Ahn JM, Kim YH, Park DW, Yun SC, et al. Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J Med 2015;372:1204-12.
32. Botman CJ, Schonberger J, Koolen S, Penn O, Botman H, et al. Does stenosis severity of native vessels influence bypass graft patency? A prospective fractional flow reserve-guided study. Ann Thorac Surg 2007;83:2093-97.
33. Toth G, De Bruyne B, Casselman F, De Vroey F, Pyxaras S, et al. Fractional flow reserve-guided versus angiography-guided coronary artery bypass graft surgery. Circulation 2013;128:1405-11.
34. Fournier S, Toth GG, De Bruyne B, Johnson NP, Ciccarelli G, et al. Six-Year Follow-Up of Fractional Flow Reserve-Guided Versus Angiography-Guided Coronary Artery Bypass Graft Surgery. Circ Cardiovasc Interv 2018;11:e006368.
35. Glineur D, Grau JB, Etienne PY, Benedetto U, Fortier JH, Papadatos S, et al. Impact of preoperative fractional flow reserve on arterial bypass graft anastomotic function: the IMPAG trial. Eur Heart J 2019; doi: 10.1093/eurheartj/ehz329. [Epub ahead of print]
36. Thuesen AL, Riber LP, Veien KT, Christiansen EH, Jensen SE, et al. Fractional flow reserve versus angiographically-guided coronary artery bypass grafting. J Am Coll Cardiol 2018;72:2732-43.
37. Toth GG, De Bruyne B, Kala P, Ribichini FL, Casselman F, et al. Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting. The GRAFFITI trial. EuroIntervention 2019;aa-608 2019. doi: 10.4244/EIJ-D-19-00463.
38. Mulukutla SR, Gleason T, Sharbaugh M, Sultan I, Marroquin OC, et al. Coronary Bypass Versus Percutaneous Revascularization in Multivessel Coronary Artery Disease. Ann Thorac Surg 2019; doi: 10.1016/j.athoracsur.2019.02.064. [Epub ahead of print]
39. Norgaard BL, Hjort J, Gaur S, Hansson N, Bøtker HE, et al. Clinical Use of Coronary CTA-Derived FFR for Decision-Making in Stable CAD. JACC Cardiovasc Imaging 2017;10:541-50.
40. Curzen NP, Nolan J, Zaman AG, Nørgaard BL, Rajani R. Does the Routine Availability of CT-Derived FFR Influence Management of Patients With Stable Chest Pain Compared to CT Angiography Alone?: The FFRCT RIPCORD Study. JACC Cardiovasc Imaging 2016;9:1188-94.
41. Nørgaard BL, Leipsic J, Gaur S, Seneviratne S, Ko BS, et al. Diagnostic Performance of Noninvasive Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography in Suspected Coronary Artery Disease. J Am Coll Cardiol 2014;63:1145-55.
42. Shiode N, Okimoto T, Tamekiyo H, Kawase T, Yamane K, et al. Comparison between the Instantaneous Wave-free Ratio and Resting Distal Coronary Artery Pressure/Aortic Pressure and the Fractional Flow Reserve: The Diagnostic Accuracy Can Be Improved by the Use of both Indices. Intern Med 2017;56:749-53.
43. Sen S, Escaned J, Malik IS, Mikhail GW, Foale RA, et al. Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study. J Am Coll Cardiol 2012;59:1392-402.
44. Petraco R, Al-Lamee R, Gotberg M, Sharp A, Hellig F, et al. Real-time use of instantaneous wave-free ratio: results of the ADVISE in-practice: an international, multicenter evaluation of instantaneous wave-free ratio in clinical practice. Am Heart J 2014;168:739-48.
